NUT Carcinoma—An Underdiagnosed Malignancy
NUT carcinoma (NC) is a rare and highly aggressive malignancy with a dismal prognosis and a median survival of 6–9 months only. Although very few cases of NC are reported each year, the true prevalence is estimated to be much higher, with NC potentially widely underdiagnosed due to the lack of aware...
Main Authors: | Ulrich M. Lauer, Martina Hinterleitner, Marius Horger, Paul V. Ohnesorge, Lars Zender |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.914031/full |
Similar Items
-
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
by: Linus D. Kloker, et al.
Published: (2022-10-01) -
NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics
by: Vanessa Moreno, et al.
Published: (2022-03-01) -
Long‐term remission of small cell lung cancer after reactivation of tuberculosis following immune‐checkpoint blockade: A case report
by: Mattia Sirgiovanni, et al.
Published: (2021-03-01) -
Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma
by: Paul V. Ohnesorge, et al.
Published: (2022-06-01) -
Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review
by: Min Chen, et al.
Published: (2024-01-01)